NCT03257020

Brief Summary

This study evaluates the relationship between BMO-MRW and RNFL thickness measured by OCT. SD-OCT exam will be performed to all patients in this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
402

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 17, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 22, 2017

Completed
Last Updated

August 25, 2017

Status Verified

August 1, 2017

Enrollment Period

1.4 years

First QC Date

August 17, 2017

Last Update Submit

August 24, 2017

Conditions

Keywords

OCTRNFLBMO-MRWGlaucoma

Outcome Measures

Primary Outcomes (1)

  • Bruch's membrane opening - minimum rim width (BMO-MRW)

    SD-OCT will be performed to the patients to measure BMO-MRW by trained glaucoma specialist.

    5~10 minutes

Secondary Outcomes (1)

  • Retinal nerve fiber layer (RNFL) thickness

    5~10 minutes

Study Arms (2)

Normal subject

Measure BMO-MRW and RNFL with SD-OCT. If the BMO-MRW and RNFL is within the normal range and those with no history of ocular disease, an intraocular pressure \< 21 mmHg, an absence of glaucomatous optic disc appearance, and a normal visual field, they will be classified into normal group.

Diagnostic Test: SD-OCT

Glaucoma patients

Measure BMO-MRW and RNFL with SD-OCT. If the BMO-MRW and RNFL is below the normal range and those with glaucomatous optic disc and two consecutive abnormal visual field test results with open angles on gonioscopy, glaucomatous optic neuropathy, RNFL defects congruent with visual field defects, they will be classified into glaucoma patients.

Diagnostic Test: SD-OCT

Interventions

SD-OCTDIAGNOSTIC_TEST

SD-OCT was performed to all subjects to measure BMO-MRW and RNFL thickness by trained glaucoma specialist. It takes about 5 to 10 minutes. The foveal location was manually detected with a live B-scan, followed by defining BMO center. A radial pattern containing 24 angular, equidistant, high-resolution 15° B-scans centered on the BMO was used to compute the neuroretinal rim parameters. The BMO points and ILM were identified and marked in each B-scan with automated software (Glaucoma Module Premium Edition, version 6.0; Heidelberg Engineering). After radial scan completed, 3 consecutive circumpapillary B-scans were followed to measure RNFL thickness at diameter of 3.5, 4.1 and 4.7mm. BMO-MRW and RNFL thickness was automatically computed globally and sectorally.

Glaucoma patientsNormal subject

Eligibility Criteria

Age19 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The patients who visited Pusan National University Hospital glaucoma clinic.

You may qualify if:

  • Age \> 18 years with a clear cornea and clear ocular media
  • BCVA ≥ 20/40
  • Refractive error within ± 6.0 diopters (D) of 0 and astigmatism ± 3.0 D of 0

You may not qualify if:

  • uveitis
  • secondary glaucoma
  • corneal abnormalities
  • non-glaucomatous optic neuropathies
  • previous trauma
  • ocular surgery or laser treatment
  • any other eye disease except glaucoma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pusan National University Hospital

Busan, 49214, South Korea

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Jiwoong Lee, M.D., Ph.D

    Medical Research Institute, Pusan National University Hospital, Busan, Korea

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2017

First Posted

August 22, 2017

Study Start

August 1, 2015

Primary Completion

December 31, 2016

Study Completion

December 31, 2016

Last Updated

August 25, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will share

De-identified individual participants data for all primary and secondary outcome measures will be shared.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
Data will be available within 12 months after study published.
Access Criteria
Data access requests will be reviewed by an external independent review panel (PNUH IRB) and if they approve, data will be provided.

Locations